Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04436796 · ClinicalTrials.gov registry record · NA
The International Diabetes Closed Loop (iDCL) Trial: Protocol 4
A NA study, sponsored by Sansum Diabetes Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT04436796 is a NA study that has completed, run by Sansum Diabetes Research Institute. The registered enrollment target is 35 participants.
The verdict
NCT04436796, a NA study, has completed, sponsored by Sansum Diabetes Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The investigators aim to compare the efficacy and safety of an AID system using an adaptive MPC algorithm versus SAP (which may or may not include PLGS; to be referred to as SAP) in people with type 1 diabetes.
Interventions
- DEVICE interoperable Artificial Pancreas System (iAPS)
- OTHER Sensor-Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2020-08-05 |
| Est. Completion | 2021-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04436796
The ClinicalTrials.gov registry entry for NCT04436796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sansum Diabetes Research Institute, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which interoperable Artificial Pancreas System (iAPS) is the first listed.
NCT04436796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04436796 about?
NCT04436796 is a clinical study titled "The International Diabetes Closed Loop (iDCL) Trial: Protocol 4". The investigators aim to compare the efficacy and safety of an AID system using an adaptive MPC algorithm versus SAP (which may or may not include PLGS; to be referred to as SAP) in people with type 1 diabetes.
What is the current status of trial NCT04436796?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2020-08-05. Estimated completion is 2021-05-10.
What interventions are being tested in trial NCT04436796?
The interventions under investigation include: interoperable Artificial Pancreas System (iAPS) (DEVICE), Sensor-Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) (OTHER).
Who is sponsoring clinical trial NCT04436796?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.